OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification
Eva Gato, Paula Guijarro-Sánchez, Isaac Alonso-García, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 4, pp. 106935-106935
Closed Access | Times Cited: 14
Eva Gato, Paula Guijarro-Sánchez, Isaac Alonso-García, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 4, pp. 106935-106935
Closed Access | Times Cited: 14
Showing 14 citing articles:
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions
Tania Blanco-Martín, Isaac Alonso-García, Lucía González-Pinto, et al.
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 5, pp. 107150-107150
Open Access | Times Cited: 13
Tania Blanco-Martín, Isaac Alonso-García, Lucía González-Pinto, et al.
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 5, pp. 107150-107150
Open Access | Times Cited: 13
Drug Discovery in the Field of β-Lactams: An Academic Perspective
Lian Jacobs, Patrick Consol, Yu Chen
Antibiotics (2024) Vol. 13, Iss. 1, pp. 59-59
Open Access | Times Cited: 12
Lian Jacobs, Patrick Consol, Yu Chen
Antibiotics (2024) Vol. 13, Iss. 1, pp. 59-59
Open Access | Times Cited: 12
Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: A global public health threat
Ting-yu Lei, Bin-bin Liao, Liang-Rui Yang, et al.
Microbiological Research (2024) Vol. 288, pp. 127839-127839
Closed Access | Times Cited: 7
Ting-yu Lei, Bin-bin Liao, Liang-Rui Yang, et al.
Microbiological Research (2024) Vol. 288, pp. 127839-127839
Closed Access | Times Cited: 7
Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa
Lucía González-Pinto, Isaac Alonso-García, Tania Blanco-Martín, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 10, pp. 2591-2597
Open Access | Times Cited: 6
Lucía González-Pinto, Isaac Alonso-García, Tania Blanco-Martín, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 10, pp. 2591-2597
Open Access | Times Cited: 6
In vitro mimicry of in vivo KPC mutations by ceftazidime-avibactam: phenotypes, mechanisms, genetic structure and kinetics of enzymatic hydrolysis
Siquan Shen, Chengkang Tang, Weiwei Yang, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Siquan Shen, Chengkang Tang, Weiwei Yang, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Investigation on Klebsiella pneumoniae in the field of extracellular vesicles
Jun Wu, Yuheng Liu, Jin Su, et al.
Deleted Journal (2025)
Open Access
Jun Wu, Yuheng Liu, Jin Su, et al.
Deleted Journal (2025)
Open Access
Rapid prediction of carbapenemases in Pseudomonas aeruginosa by imipenem/relebactam and MALDI-TOF MS
Ana Candela, María Fernández-Billón, Pablo Aja‐Macaya, et al.
Journal of Clinical Microbiology (2025)
Open Access
Ana Candela, María Fernández-Billón, Pablo Aja‐Macaya, et al.
Journal of Clinical Microbiology (2025)
Open Access
Complex evolutionary trajectories in vivo of two novel KPC variants conferring ceftazidime-avibactam resistance
Chengkang Tang, Siquan Shen, Weiwei Yang, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 3, pp. 107265-107265
Closed Access | Times Cited: 1
Chengkang Tang, Siquan Shen, Weiwei Yang, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 3, pp. 107265-107265
Closed Access | Times Cited: 1
In Vitro Resistance-Predicting Studies and In Vitro Resistance-Related Parameters—A Hit-to-Lead Perspective
Joanna Krajewska, Stefan Tyski, Agnieszka E. Laudy
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1068-1068
Open Access | Times Cited: 1
Joanna Krajewska, Stefan Tyski, Agnieszka E. Laudy
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1068-1068
Open Access | Times Cited: 1
In-Vitro multiparametric analysis of imipenem resistance in Bacteria caused by acquisition of foreign DNA and natural mutations
Johenis del Carmen De La Cruz Chavez, Juan Manuel Pedraza, Johana Husserl
Journal of environmental chemical engineering (2024) Vol. 12, Iss. 5, pp. 113840-113840
Open Access
Johenis del Carmen De La Cruz Chavez, Juan Manuel Pedraza, Johana Husserl
Journal of environmental chemical engineering (2024) Vol. 12, Iss. 5, pp. 113840-113840
Open Access
In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes
Salud Rodríguez-Pallares, Tania Blanco-Martín, Emilio Lence, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access
Salud Rodríguez-Pallares, Tania Blanco-Martín, Emilio Lence, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access
Reversion of KPC-114 to KPC-2 in ceftazidime-avibactam- resistant/meropenem-susceptible Klebsiella pneumoniae ST11 is related to low mutation rates
Jesus G. M. Pariona, Felipe Vásquez-Ponce, Johana Becerra, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 10
Open Access
Jesus G. M. Pariona, Felipe Vásquez-Ponce, Johana Becerra, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 10
Open Access
Mutant prevention concentrations, in vitro resistance evolution dynamics, and mechanisms of resistance to imipenem and imipenem/relebactam in carbapenem-susceptible Klebsiella pneumoniae isolates showing ceftazidime/avibactam resistance
Tania Blanco-Martín, Lucía González-Pinto, Pablo Aja‐Macaya, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
Tania Blanco-Martín, Lucía González-Pinto, Pablo Aja‐Macaya, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
Multiple mechanisms mediate aztreonam-avibactam resistance in Klebsiella pneumoniae: driven by KPC-2 and OmpK36 mutations
Xin Xiang, Jingchun Kong, Jia Zhang, et al.
International Journal of Antimicrobial Agents (2024) Vol. 65, Iss. 2, pp. 107425-107425
Closed Access
Xin Xiang, Jingchun Kong, Jia Zhang, et al.
International Journal of Antimicrobial Agents (2024) Vol. 65, Iss. 2, pp. 107425-107425
Closed Access
